{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:40:56Z","timestamp":1789378856364,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.exer.2016.03.023","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T18:37:23Z","timestamp":1459622243000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Rebecca E.H.","family":"Whiting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline W.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2016.03.023_bib1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0014-4835(89)80027-2","article-title":"Selective presence of acid hydrolases in the interphotoreceptor matrix","volume":"49","author":"Adler","year":"1989","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.03.023_bib2","first-page":"65","article-title":"Proteins of the bovine interphotoreceptor matrix: retinoid binding and other functions","volume":"190","author":"Adler","year":"1985","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.exer.2016.03.023_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/02713688209000781","article-title":"Lysosomal enzymes in the interphotoreceptor matrix: acid protease","volume":"2","author":"Adler","year":"1983","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2016.03.023_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A\u00a0frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metabolism"},{"key":"10.1016\/j.exer.2016.03.023_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11910-013-0366-z","article-title":"Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum","volume":"13","author":"Cotman","year":"2013","journal-title":"Curr. Neurology Neurosci. Rep."},{"key":"10.1016\/j.exer.2016.03.023_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10633-013-9388-8","article-title":"Guidelines for clinical electroretinography in the dog: 2012 update","volume":"127","author":"Ekesten","year":"2013","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.exer.2016.03.023_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2015.04.001","article-title":"Golden Retriever dogs with neuronal ceroid lipofuscinosis have a two-base-pair deletion and frameshift in CLN5","volume":"115","author":"Gilliam","year":"2015","journal-title":"Mol. Genet. Metabolism"},{"key":"10.1016\/j.exer.2016.03.023_bib8","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1167\/iovs.08-1712","article-title":"Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"49","author":"Katz","year":"2008","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2016.03.023_bib9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","volume":"92","author":"Katz","year":"2014","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.exer.2016.03.023_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2460\/ajvr.2005.66.67","article-title":"Assessment of retinal function and characterization of lysosomal storage body accumulation in the retinas and brains of Tibetan Terriers with ceroid-lipofuscinosis","volume":"66","author":"Katz","year":"2005","journal-title":"Am. J. Veterinary Res."},{"key":"10.1016\/j.exer.2016.03.023_bib11","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2016.03.023_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000431143","article-title":"Routes for drug delivery to the eye and retina: intravitreal injections","volume":"55","author":"Meyer","year":"2016","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.exer.2016.03.023_bib13","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1825","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exer.2016.03.023_bib14","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"Mole","year":"2011"},{"key":"10.1016\/j.exer.2016.03.023_bib15","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jnr.23287","article-title":"Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis","volume":"91","author":"Morgan","year":"2013","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.exer.2016.03.023_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/jnr.23332","article-title":"Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis","volume":"92","author":"Morgan","year":"2014","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.exer.2016.03.023_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.exer.2016.03.023_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2014.09.004","article-title":"Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis","volume":"114","author":"Vuillemenot","year":"2015","journal-title":"Mol. Genet. Metabolism"},{"key":"10.1016\/j.exer.2016.03.023_bib19","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","article-title":"Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses","volume":"1832","author":"Warrier","year":"2013","journal-title":"Biochimica Biophysica Acta"},{"key":"10.1016\/j.exer.2016.03.023_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","article-title":"Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"125","author":"Whiting","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.03.023_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.exer.2013.10.006","article-title":"Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"116","author":"Whiting","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.03.023_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exer.2015.02.012","article-title":"Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis","volume":"134","author":"Whiting","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.03.023_bib23","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1167\/iovs.13-12012","article-title":"Quantitative assessment of the canine pupillary light reflex","volume":"54","author":"Whiting","year":"2013","journal-title":"Investigative Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483516300550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483516300550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:59:42Z","timestamp":1757998782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483516300550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":23,"alternative-id":["S0014483516300550"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2016.03.023","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2016.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}